Roles of low‐density lipoprotein receptor‐related protein 1 in tumors

Low‐density lipoprotein receptor‐related protein 1 (LRP1, also known as CD91), a multifunctional endocytic and cell signaling receptor, is widely expressed on the surface of multiple cell types such as hepatocytes, fibroblasts, neurons, astrocytes, macrophages, smooth muscle cells, and malignant cells. Emerging in vitro and in vivo evidence demonstrates that LRP1 is critically involved in many processes that drive tumorigenesis and tumor progression. For example, LRP1 not only promotes tumor cell migration and invasion by regulating matrix metalloproteinase (MMP)‐2 and MMP‐9 expression and functions but also inhibits cell apoptosis by regulating the insulin receptor, the serine/threonine protein kinase signaling pathway, and the expression of Caspase‐3. LRP1‐mediated phosphorylation of the extracellular signal‐regulated kinase pathway and c‐jun N‐terminal kinase are also involved in tumor cell proliferation and invasion. In addition, LRP1 has been shown to be down‐regulated by microRNA‐205 and methylation of LRP1 CpG islands. Furthermore, a novel fusion gene, LRP1 ‐ SNRNP25 , promotes osteosarcoma cell invasion and migration. Only by understanding the mechanisms of these effects can we develop novel diagnostic and therapeutic strategies for cancers mediated by LRP1.